Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
3 "Epigenomics"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Review Articles
Thyroid
Thyroid Function across the Lifespan: Do Age-Related Changes Matter?
John P. Walsh
Endocrinol Metab. 2022;37(2):208-219.   Published online April 14, 2022
DOI: https://doi.org/10.3803/EnM.2022.1463
  • 6,055 View
  • 339 Download
  • 12 Web of Science
  • 15 Crossref
AbstractAbstract PDFPubReader   ePub   
Circulating concentrations of thyrotropin (TSH) and thyroxine (T4) are tightly regulated. Each individual has setpoints for TSH and free T4 which are genetically determined, and subject to environmental and epigenetic influence. Pituitary-thyroid axis setpoints are probably established in utero, with maturation of thyroid function continuing until late gestation. From neonatal life (characterized by a surge of TSH and T4 secretion) through childhood and adolescence (when free triiodothyronine levels are higher than in adults), thyroid function tests display complex, dynamic patterns which are sexually dimorphic. In later life, TSH increases with age in healthy older adults without an accompanying fall in free T4, indicating alteration in TSH setpoint. In view of this, and evidence that mild subclinical hypothyroidism in older people has no health impact, a strong case can be made for implementation of age-related TSH reference ranges in adults, as is routine in children.

Citations

Citations to this article as recorded by  
  • The ageing thyroid: implications for longevity and patient care
    Diana van Heemst
    Nature Reviews Endocrinology.2024; 20(1): 5.     CrossRef
  • Incidence and Determinants of Spontaneous Normalization of Subclinical Hypothyroidism in Older Adults
    Evie van der Spoel, Nicolien A van Vliet, Rosalinde K E Poortvliet, Robert S Du Puy, Wendy P J den Elzen, Terence J Quinn, David J Stott, Naveed Sattar, Patricia M Kearney, Manuel R Blum, Heba Alwan, Nicolas Rodondi, Tinh-Hai Collet, Rudi G J Westendorp,
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e1167.     CrossRef
  • Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications
    Rosalie B. T. M. Sterenborg, Inga Steinbrenner, Yong Li, Melissa N. Bujnis, Tatsuhiko Naito, Eirini Marouli, Tessel E. Galesloot, Oladapo Babajide, Laura Andreasen, Arne Astrup, Bjørn Olav Åsvold, Stefania Bandinelli, Marian Beekman, John P. Beilby, Jette
    Nature Communications.2024;[Epub]     CrossRef
  • Evaluation of multiple organophosphate insecticide exposure in relation to altered thyroid hormones in NHANES 2007‐2008 adult population
    Massira Ousseni Diawara, Songtao Li, Mingzhi Zhang, Francis Manyori Bigambo, Xu Yang, Xu Wang, Tianyu Dong, Di Wu, Chenghao Yan, Yankai Xia
    Ecotoxicology and Environmental Safety.2024; 273: 116139.     CrossRef
  • Thyroid-function reference ranges in the diagnosis of thyroid dysfunction in adults
    Salman Razvi
    Nature Reviews Endocrinology.2024; 20(5): 253.     CrossRef
  • Association between exposure to chemical mixtures and epigenetic ageing biomarkers: Modifying effects of thyroid hormones and physical activity
    Wanying Shi, Jianlong Fang, Huimin Ren, Peijie Sun, Juan Liu, Fuchang Deng, Shuyi Zhang, Qiong Wang, Jiaonan Wang, Shilu Tong, Song Tang, Xiaoming Shi
    Journal of Hazardous Materials.2024; 469: 134009.     CrossRef
  • DNA Methylation in Autoimmune Thyroid Disease
    Nicole Lafontaine, Scott G Wilson, John P Walsh
    The Journal of Clinical Endocrinology & Metabolism.2023; 108(3): 604.     CrossRef
  • A Causality between Thyroid Function and Bone Mineral Density in Childhood: Abnormal Thyrotropin May Be Another Pediatric Predictor of Bone Fragility
    Dongjin Lee, Moon Ahn
    Metabolites.2023; 13(3): 372.     CrossRef
  • Serum Lipidomic Analysis Reveals Biomarkers and Metabolic Pathways of Thyroid Dysfunction
    Hua Dong, Wenjie Zhou, Xingxu Yan, Huan Zhao, Honggang Zhao, Yan Jiao, Guijiang Sun, Yubo Li, Zuncheng Zhang
    ACS Omega.2023; 8(11): 10355.     CrossRef
  • Developmental and environmental modulation of fecal thyroid hormone levels in wild Assamese macaques (Macaca assamensis)
    Verena Behringer, Michael Heistermann, Suchinda Malaivijitnond, Oliver Schülke, Julia Ostner
    American Journal of Primatology.2023;[Epub]     CrossRef
  • Prevalence of Functional Alterations and the Effects of Thyroid Autoimmunity on the Levels of TSH in an Urban Population of Colombia: A Population-Based Study
    Hernando Vargas-Uricoechea, Valentina Agredo-Delgado, Hernando David Vargas-Sierra, María V. Pinzón-Fernández
    Endocrine, Metabolic & Immune Disorders - Drug Targets.2023; 23(6): 857.     CrossRef
  • Genetic determinants of thyroid function in children
    Tessa A Mulder, Purdey J Campbell, Peter N Taylor, Robin P Peeters, Scott G Wilson, Marco Medici, Colin Dayan, Vincent V W Jaddoe, John P Walsh, Nicholas G Martin, Henning Tiemeier, Tim I M Korevaar
    European Journal of Endocrinology.2023; 189(2): 164.     CrossRef
  • Relationship between Thyroid CT Density, Volume, and Future TSH Elevation: A 5-Year Follow-Up Study
    Tomohiro Kikuchi, Shouhei Hanaoka, Takahiro Nakao, Yukihiro Nomura, Takeharu Yoshikawa, Md Ashraful Alam, Harushi Mori, Naoto Hayashi
    Life.2023; 13(12): 2303.     CrossRef
  • Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status
    Katleen Van Uytfanghe, Joel Ehrenkranz, David Halsall, Kelly Hoff, Tze Ping Loh, Carole A. Spencer, Josef Köhrle
    Thyroid®.2023; 33(9): 1013.     CrossRef
  • Blood hormones and suicidal behaviour: A systematic review and meta-analysis
    Xue-Lei Fu, Xia Li, Jia-Mei Ji, Hua Wu, Hong-Lin Chen
    Neuroscience & Biobehavioral Reviews.2022; 139: 104725.     CrossRef
Close layer
Thyroid
Mechanisms of TERT Reactivation and Its Interaction with BRAFV600E
Young Shin Song, Young Joo Park
Endocrinol Metab. 2020;35(3):515-525.   Published online September 22, 2020
DOI: https://doi.org/10.3803/EnM.2020.304
  • 7,944 View
  • 198 Download
  • 9 Web of Science
  • 10 Crossref
AbstractAbstract PDFPubReader   ePub   
The telomerase reverse transcriptase (TERT) gene, which is repressed in most differentiated human cells, can be reactivated by somatic TERT alterations and epigenetic modulations. Moreover, the recruitment, accessibility, and binding of transcription factors also affect the regulation of TERT expression. Reactivated TERT contributes to the development and progression of cancer through telomere lengthening-dependent and independent ways. In particular, because of recent advances in high-throughput sequencing technologies, studies on genomic alterations in various cancers that cause increased TERT transcriptional activity have been actively conducted. TERT reactivation has been reported to be associated with poor prognosis in several cancers, and TERT promoter mutations are among the most potent prognostic markers in thyroid cancer. In particular, when a TERT promoter mutation coexists with the BRAFV600E mutation, these mutations exert synergistic effects on a poor prognosis. Efforts have been made to uncover the mechanisms of these synergistic interactions. In this review, we discuss the role of TERT reactivation in tumorigenesis, the mechanisms of TERT reactivation across all human cancers and in thyroid cancer, and the mechanisms of interactions between BRAFV600E and TERT promoter mutations.

Citations

Citations to this article as recorded by  
  • Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing
    Lili Deng, Jingjing Zeng, Jin Feng Qiu, Li Hua Yang, Jie Ma
    Medicine.2023; 102(32): e34523.     CrossRef
  • Genomic Analysis in the Categorization of Poorly Differentiated Primary Liver Carcinomas
    Alexander T. Kikuchi, Sarah Umetsu, Nancy Joseph, Sanjay Kakar
    American Journal of Surgical Pathology.2023; 47(11): 1207.     CrossRef
  • Telomerase and hallmarks of cancer: An intricate interplay governing cancer cell evolution
    Naveen kumar, Gautam Sethi
    Cancer Letters.2023; 578: 216459.     CrossRef
  • Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Tumour Entity with a Short History. A Review on Challenges in Our Microscopes, Molecular and Ultrasonographic Profile
    Ivana Kholová, Elina Haaga, Jaroslav Ludvik, David Kalfert, Marie Ludvikova
    Diagnostics.2022; 12(2): 250.     CrossRef
  • Does Locally Advanced Thyroid Cancer Have Different Features? Results from a Single Academic Center
    Marco Dell’Aquila, Pietro Tralongo, Giuseppe De Ruggieri, Mariangela Curatolo, Luca Revelli, Celestino Pio Lombardi, Alfredo Pontecorvi, Guido Fadda, Luigi Maria Larocca, Marco Raffaelli, Liron Pantanowitz, Esther Diana Rossi
    Journal of Personalized Medicine.2022; 12(2): 221.     CrossRef
  • Adult Wilms Tumor
    Pedram Argani, Satish K. Tickoo, Andres Matoso, Christine A. Pratilas, Rohit Mehra, Maria Tretiakova, Mathilde Sibony, Alan K. Meeker, Ming-Tseh Lin, Victor E. Reuter, Jonathan I. Epstein, Jeffrey Gagan, Doreen N. Palsgrove
    American Journal of Surgical Pathology.2022; 46(7): 988.     CrossRef
  • Prospective Analysis of TERT Promoter Mutations in Papillary Thyroid Carcinoma at a Single Institution
    Yun-Suk Choi, Seong-Woon Choi, Jin-Wook Yi
    Journal of Clinical Medicine.2021; 10(10): 2179.     CrossRef
  • How limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid‐based cytology: Role of TERT promoter and BRAF V600E mutation analysis
    Marco Dell’Aquila, Vincenzo Fiorentino, Maurizio Martini, Sara Capodimonti, Tonia Cenci, Celestino Pio Lombardi, Marco Raffaelli, Alfredo Pontecorvi, Guido Fadda, Liron Pantanowitz, Luigi Maria Larocca, Esther Diana Rossi
    Cancer Cytopathology.2021; 129(10): 819.     CrossRef
  • Human telomerase reverse transcriptase and telomeres in cancer
    Anurag Mehta, Shrinidhi Nathany
    Journal of Current Oncology.2021; 4(1): 1.     CrossRef
  • Mutation in Genes Encoding Key Functional Groups Additively Increase Mortality in Patients with BRAFV600E-Mutant Advanced Papillary Thyroid Carcinoma
    Eyun Song, Meihua Jin, Ahreum Jang, Min Ji Jeon, Dong Eun Song, Hye Jin Yoo, Won Bae Kim, Young Kee Shong, Won Gu Kim
    Cancers.2021; 13(22): 5846.     CrossRef
Close layer
Epigenetic Modifications: Novel Therapeutic Approach for Thyroid Cancer
Xuguang Zhu, Sheue-yann Cheng
Endocrinol Metab. 2017;32(3):326-331.   Published online September 18, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.3.326
  • 3,889 View
  • 39 Download
  • 13 Web of Science
  • 13 Crossref
AbstractAbstract PDFPubReader   

The incidence of thyroid cancer is growing the fastest among all cancers in the United States, especially in women. The number of patients with thyroid neoplasm is part of an even larger number of patients who often need to undergo an operation to exclude a cancer diagnosis. While differentiated thyroid cancer (papillary thyroid cancer and follicular thyroid cancer) accounts for most cases of thyroid cancer and has a relatively good prognosis, effective treatments for patients with de-differentiated and anaplastic thyroid cancer are still gravely needed. Despite progress in the identification of genetic changes in thyroid cancer, the impact of aberrant epigenetic alterations on thyroid cancer remains to be fully elucidated. Understanding of the roles of epigenetic changes in thyroid cancer could open new opportunities for the identification of innovative molecular targets for novel treatment modalities, especially for anaplastic thyroid cancer for which treatment is very limited. This article briefly reviews the studies that exemplify the potential for and promise of using epigenetic regulators in the treatment of thyroid cancer.

Citations

Citations to this article as recorded by  
  • Challenges and Coping Strategies of Older Adults in the Aftermath of Kahramanmaraş Earthquake in Türkiye: A Qualitative Research
    Nilgun Kuru Alici, Bilge Kalanlar
    Journal of Applied Gerontology.2024;[Epub]     CrossRef
  • CircRTN1 stimulates HMGB1 to regulate the malignant progression of papillary thyroid cancer by sponging miR-101-3p
    Mei Zheng, Lingli Xu, Cuifeng Wei, Wenzhen Guan
    Hormones.2023; 22(2): 281.     CrossRef
  • The expression of HDAC9 and P300 in papillary thyroid carcinoma cell line
    Hatice Ozisik, Berrin Ozdil, Aslı Suner, Murat Sipahi, Mehmet Erdogan, Sevki Cetinkalp, Gokhan Ozgen, Fusun Saygili, Gulgun Oktay, Huseyin Aktug
    Pathology - Research and Practice.2023; 243: 154385.     CrossRef
  • Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications
    Valerie Jacquemin, Mathieu Antoine, Geneviève Dom, Vincent Detours, Carine Maenhaut, Jacques E. Dumont
    Cancers.2022; 14(2): 280.     CrossRef
  • Thyroid Carcinoma: A Review for 25 Years of Environmental Risk Factors Studies
    Eva Kruger, Eman A. Toraih, Mohammad H. Hussein, Shaimaa A. Shehata, Amani Waheed, Manal S. Fawzy, Emad Kandil
    Cancers.2022; 14(24): 6172.     CrossRef
  • Study of Essential and Toxic Metal Imbalances in the Scalp Hair of Thyroid Cancer Patients in Comparison with Healthy Donors
    Kalsoom Bibi, Munir H. Shah
    Biological Trace Element Research.2021; 199(2): 500.     CrossRef
  • Modern concepts of the molecular pathogenesis of thyroid cancer
    A. A. Mikhailova, A. V. Shestakov, K. A. Chubakova, E. V. Kolokolova, V. Yu. Eliseev, M. Ya. Kostyaeva, E. G. Akperov, V. E. Pilipenko, T. V. Saprina, M. R. Mukhamedov, E. L. Choinzonov
    Advances in Molecular Oncology.2021; 8(2): 8.     CrossRef
  • Effect of valproic acid on miRNAs affecting histone deacetylase in a model of anaplastic thyroid cancer
    Nur Selvi Gunel, Nihal Birden, Cansu Caliskan Kurt, Bakiye Goker Bagca, Behrouz Shademan, Fatma Sogutlu, Neslihan Pinar Ozates, Cigir Biray Avci
    Molecular Biology Reports.2021; 48(8): 6085.     CrossRef
  • Histone Deacetylase Inhibitors and Papillary Thyroid Cancer
    Eleftherios Spartalis, Konstantinos Kotrotsios, Dimosthenis Chrysikos, Michael Spartalis, Stavroula A. Paschou, Dimitrios Schizas, Konstantinos Tsamakis, Dimitrios Dimitroulis, Theodore Troupis, Nikolaos Nikiteas
    Current Pharmaceutical Design.2021; 27(18): 2199.     CrossRef
  • HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer
    Ching-Ling Lin, Ming-Lin Tsai, Chun-Yu Lin, Kai-Wen Hsu, Wen-Shyang Hsieh, Wei-Ming Chi, Li-Chi Huang, Chia-Hwa Lee
    International Journal of Molecular Sciences.2019; 20(2): 454.     CrossRef
  • Systems Biology Approaches to Investigate Genetic and Epigenetic Molecular Progression Mechanisms for Identifying Gene Expression Signatures in Papillary Thyroid Cancer
    Shan-Ju Yeh, Chien-Yu Lin, Cheng-Wei Li, Bor-Sen Chen
    International Journal of Molecular Sciences.2019; 20(10): 2536.     CrossRef
  • Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells
    Valentina Maggisano, Marilena Celano, Saverio Massimo Lepore, Marialuisa Sponziello, Francesca Rosignolo, Valeria Pecce, Antonella Verrienti, Federica Baldan, Catia Mio, Lorenzo Allegri, Marianna Maranghi, Rosa Falcone, Giuseppe Damante, Diego Russo, Stef
    Endocrine.2019; 63(3): 545.     CrossRef
  • Role of Emerging Environmental Risk Factors in Thyroid Cancer: A Brief Review
    Maria Fiore, Gea Oliveri Conti, Rosario Caltabiano, Antonino Buffone, Pietro Zuccarello, Livia Cormaci, Matteo Angelo Cannizzaro, Margherita Ferrante
    International Journal of Environmental Research and Public Health.2019; 16(7): 1185.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism